BOM Brabant Ventures

STENTiT is a company that specializes in the development of regenerative stents aimed at restoring arteries. Its primary focus is on creating biodegradable endovascular implants that promote a natural healing response in patients. These innovative stents facilitate the circulation of blood cells, which work to replace the implant with new vascular tissue, effectively restoring the artery from the inside. By offering these advanced medical solutions, STENTiT enables healthcare professionals to treat patients suffering from cardiovascular diseases more effectively.

Developer of tumor localization technology designed to improve care for cancer patients. The company's technology uses a tiny implanted magnetic seed to precisely mark the tumor and a detection probe to accurately locate the seed during surgery, enabling patients to receive affordable cancerous tumor surgery and improved surgical care.

We started ChainCargo because of a strong inner urge to approach logistics differently. We believe that with the current capacity we can transport more. Simply by smarter use of the available capacity in existing transport movements. We want to change the way of thinking in logistics and we believe that we can transport more volume and more efficient with the current capacity of vehicles. We do that by making available capacity visible and accessible. This is realized via our platform which connects the shipment to the carrier based on sustainable business rules. An optimization for: Carriers: a better occupancy of their loading capacity Shippers: online order booking platform, live track & trace and more cost efficient Society: less pressure on infrastructure and reduction of CO2 emissions

Developer of business management platform intended to create and manage plug-and-play edge artificial intelligence (AI) services. The company's platform offers efficient AI or ML model deployment, monitoring, and governance in the cloud, in a browser, on the edge, and any device with a minimal amount of memory, enabling clients to access AI services with secure, modular, and run fully locally.

Developer of a robotic platform intended to automate labor-dependent tasks for farmers. The company's platform provides single-row autonomous weeding robots and focuses on organic crops that rely on manual weeding and organic farmers' operational costs using modular wheelbases designed to fit any field layout, enabling farmers to cut down on operating costs, increase biodiversity, and restore soil.

Microsure B.V., founded in 2016 and based in Son, Netherlands, specializes in the development of advanced robotic systems for microsurgery. The company's flagship product, MUSA, is designed to assist surgeons in performing intricate procedures, including lymphatic surgery, free flap surgery, and hand surgery. The Microsure motion stabilizer system enhances surgical precision and control, addressing the physical limitations faced by microsurgeons. This technology aims to improve the quality of microsurgical procedures, thus expanding treatment options for patients. The system has demonstrated its efficacy in clinical trials, successfully facilitating microsurgical operations for lymphedema at Maastricht UMC+. Microsure is focused on accelerating the market introduction and sales of its innovative surgical systems.

Shypple B.V. is a logistics company based in Rotterdam, Netherlands, founded in 2016. It provides a comprehensive range of services including door pick-ups, customs brokerage, ocean, air, and rail freight, as well as on-demand warehousing. The company also offers trucking, finance, insurance, and customs services, supported by a digital freight forwarding platform. This central web application enhances visibility across the supply chain, enabling efficient collaboration among all parties involved in international trade. Shypple's platform allows users to compare pricing from various carriers and optimize routing options, facilitating quicker and more transparent management of freight shipments. The company prides itself on offering 24/7 support, ensuring that clients receive attentive service without compromising the personal touch typical of traditional freight forwarders.

Developer of fully automated food waste monitor equipment designed to make the food system sustainable. The company's camera runs an artificial intelligence image recognition algorithm that recognizes and provides hospitality organizations with a complete insight into their food waste ingredients from an image, enabling restaurants to quantify huge volumes of wasted food through image recognition.

Xyall is a global innovator in molecular pathology, specializing in the development of advanced tissue dissection technology. This platform automates and digitizes the tissue dissection workflow, enhancing accuracy, scalability, and cost-efficiency while minimizing the risk of cross-contamination. Xyall's technology ensures the traceability of each sample and test, allowing pathologists to obtain reliable molecular diagnostic results in real-time. By streamlining the dissection process, Xyall aims to improve the overall efficiency and effectiveness of molecular diagnostics in the healthcare sector.

Knowingo+ is a discover the smartest mobile learning platform.

Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis. Citryll was established in 2015 and is headquartered in Oss, The Netherlands.

Dens B.V., founded in 2018 and based in Helmond, the Netherlands, specializes in renewable energy solutions by manufacturing generators that convert formic acid into hydrogen and subsequently into electricity. The company's flagship product, DENS X2, serves as a sustainable and silent alternative to traditional diesel generators, particularly in areas lacking power supplies. Dens B.V. focuses on developing machines that store and regenerate renewable energy, ensuring a reliable energy source regardless of time and location. This innovation aims to provide clients with a zero-emission power solution that minimizes environmental impact while eliminating the noise associated with conventional generators.

SamanTree Medical SA is a Swiss company specializing in the development of innovative medical microscopy devices aimed at enhancing cancer treatment and surgical outcomes. Founded in 2014 and based in Ecublens, the company focuses on micro-optics-based digital microscopy systems that provide an extensive field of view for various applications, including research, diagnostics, and surgery. Its flagship product, a surgical digital microscope, enables real-time visualization of cellular structures within living tissue, facilitating precise assessment of tumor margins. This technology allows surgeons to achieve full margin control and make informed decisions during procedures, ultimately improving resection accuracy, reducing re-operation rates, and decreasing overall procedure costs. By enabling immediate visualization of cancerous cells during surgery, SamanTree Medical's devices significantly enhance patient care and outcomes in cancer surgery.

Cytosmartb develops smart devices to use in laboratories around the world. It provides CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni for businesses and individuals. The clients of the company are Fontys, THM, Roche, University of Oxford, EMBL, and University of St Andrews. Cytosmart is a Netherlands-based company that was founded in 2012.

Enpicom is a bioinformatics software engineering company that specializes in providing innovative solutions for scientists in biopharma and academic research. The company develops products aimed at enhancing the discovery and development of novel immunotherapies and vaccines. Enpicom's flagship offering is the ImmunoGenomiX (IGX) Platform, which facilitates the management, storage, analysis, visualization, and comparison of immune repertoire sequencing data from T and B cell receptors. By utilizing a combination of biological expertise, bioinformatics method development, and software engineering, Enpicom's technology-agnostic and code-free software simplifies the complexities associated with immune repertoire analysis. This enables researchers to concentrate on their scientific inquiries and advancements in antibody discovery, ultimately contributing to improved human health.

Additive Industries B.V., established in 2012 and based in Eindhoven, Netherlands, specializes in designing and manufacturing industrial metal additive manufacturing systems. The company focuses on providing a modular 3D printing system, which allows for the production of functional parts across various high-end industrial markets, including aerospace, automotive, medical technology, and high-tech equipment. Its innovative technology enhances reproducibility, productivity, and flexibility, effectively transforming the industrial value chain. By enabling the creation of lighter and more complex parts with improved thermal performance, Additive Industries supports companies in optimizing their production activities. The company boasts a team of highly experienced engineers and professionals from the high-tech equipment sector, underscoring its commitment to advancing additive manufacturing solutions.

DegenRx is a biopharmaceutical company focused on developing innovative therapeutic solutions for neurodegenerative diseases. The company specializes in gene therapy, utilizing adeno-associated viral vectors to deliver genes directly into the brain. This approach aims to stimulate the local production of therapeutic antibodies, providing potential treatments for central nervous system disorders, including Alzheimer's and Parkinson's diseases. By advancing these targeted therapies, DegenRx seeks to enhance treatment options for patients suffering from these debilitating conditions.

Cytosmartb develops smart devices to use in laboratories around the world. It provides CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni for businesses and individuals. The clients of the company are Fontys, THM, Roche, University of Oxford, EMBL, and University of St Andrews. Cytosmart is a Netherlands-based company that was founded in 2012.